<DOC>
	<DOCNO>NCT03073356</DOCNO>
	<brief_summary>Ketones may beneficial effect myocardial metabolism hemodynamics . In present study , healthy test subject patient heart failure reduce ejection fraction investigate randomized cross-over design ketone infusion placebo . Myocardial efficiency hemodynamics evaluate .</brief_summary>
	<brief_title>Ketones Heart Failure - Effects Cardiac Efficiency</brief_title>
	<detailed_description>The prevalence patient heart failure reduce ejection fraction ( HFrEF ) 1-2 % , lifetime risk heart failure age 55 year approximately 30 % . Despite advance treatment , hospitalization rate mortality remain high . It well know myocardial metabolism change development HFrEF , may contribute contractile dysfunction . However , myocardium consider omnivore regard substrate utilization , confer important adaptive property . Hence , metabolize either glucose , lipid , lactate , amino acid ketone ( 3-hydroxybutyrate ) depend substrate availability , hormonal status cardiac demand . These substrate differ regard myocardial energy efficiency ( MEE ) ( cardiac work relate oxygen consumption ) . Since high MEE associate good prognosis HFrEF , manipulate substrate uptake could new treatment modality heart failure patient . Recently , show human myocardium increase 3-hydroxybutyrate ( 3-OHB ) metabolism development HFrEF . These change may beneficial 3-OHB could increase myocardial efficiency lower oxidative stress scavenge free radical . However , investigated clinical trial , effect 3-OHB cardiac function , oxygen consumption perfusion remain undetermined HFrEF patient . In present study investigator evaluate whether elevated circulate 3-OHB affect myocardial oxygen consumption , MEE perfusion healthy subject patient HFrEF , whether 3-OHB affect hemodynamics contractile function . 10 healthy test subject 20 HFrEF patient subject placebo 3-OHB infusion randomize cross-over design . Acetate-PET , echocardiography right side heart catheterization apply .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<criteria>For participant heart failure : Symptoms Heart failure NYHA 23 LVEF &lt; 40 % For participant : Negative HCG woman pregnant age Significant cardiac valve disease Signs history major myocardial infarction ( STEMI ) within 3 month Other disease treatment make subject unsuitable study participation Treatment diabetes HbA1c level &gt; 7 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Myocardial metabolism</keyword>
	<keyword>Positron emission tomography</keyword>
	<keyword>Echocardiography</keyword>
	<keyword>Right side heart catheterization</keyword>
</DOC>